Core Insights - Uber Technologies, Inc. is set to announce its fiscal third-quarter earnings for 2025 on November 4, with a market cap of $196.2 billion [1] - Analysts predict a diluted EPS of $0.67 for the upcoming quarter, representing a 44.2% decline from $1.20 in the same quarter last year [2] - For the full fiscal year, EPS is expected to be $2.90, down 36.4% from $4.56 in fiscal 2024, but projected to rise to $3.47 in fiscal 2026, a 19.7% increase year over year [3] Performance Metrics - Over the past 52 weeks, Uber's stock has increased by 11%, underperforming the S&P 500 Index's 13.4% gains and the Technology Select Sector SPDR Fund's 20.4% gains [4] - In Q2, Uber reported an EPS of $0.63, exceeding Wall Street's expectation of $0.62, with revenue of $12.7 billion, surpassing the forecast of $12.5 billion [5] Analyst Sentiment - The consensus among analysts is bullish, with a "Strong Buy" rating for Uber stock; 34 out of 49 analysts recommend a "Strong Buy," while 4 suggest a "Moderate Buy," and 11 give a "Hold" [6] - The average analyst price target for Uber is $109, indicating a potential upside of 15.6% from current levels [6]

Company Overview - Bio-Techne Corporation (TECH) is headquartered in Minneapolis, Minnesota, and specializes in developing, manufacturing, and selling life science reagents, instruments, and services for research, diagnostics, and bioprocessing markets, with a market cap of $9.3 billion [1] Earnings Expectations - Analysts expect TECH to report a profit of $0.37 per share on a diluted basis for the fiscal first quarter of 2026, which is unchanged from the same quarter last year [2] - For the full fiscal year, analysts project an EPS of $1.76, reflecting a 2.9% increase from $1.71 in fiscal 2025, and an expected rise to $2 in fiscal 2027, representing a 13.6% year-over-year growth [3] Stock Performance - TECH stock has underperformed the S&P 500 Index, which gained 14.4% over the past 52 weeks, with TECH shares down 18.7% during the same period [4] - The stock also underperformed the Health Care Select Sector SPDR Fund, which saw a 7.8% loss in the same timeframe [4] Recent Financial Results - On August 6, TECH reported its Q4 results, with an adjusted EPS of $0.53, surpassing Wall Street expectations of $0.50, and revenue of $317 million, exceeding forecasts of $315.4 million [5] Analyst Ratings - The consensus opinion on TECH stock is bullish, with a "Strong Buy" rating overall; out of 16 analysts, 11 recommend "Strong Buy," one suggests "Moderate Buy," and four give a "Hold" rating [6] - The average analyst price target for TECH is $66.77, indicating a potential upside of 11.9% from current levels [6]

Core Insights - Alcoa Corporation (NYSE: AA) is scheduled to report earnings on October 22, 2025, with expectations of moderating aluminum pricing improvements as the quarter ends and into Q3 '25 [1] Group 1: Company Performance - The company is anticipated to experience improved economics, which may positively influence its earnings report [1] Group 2: Analyst Background - Michael Del Monte, a buy-side equity analyst with over 5 years of industry experience, emphasizes that investment recommendations should consider the entire investment ecosystem rather than evaluating a company in isolation [1]

Core Viewpoint - Alcoa Corporation (NYSE: AA) is expected to report earnings on October 22, 2025, with aluminum pricing improvements moderating towards the end of the quarter and into Q3 '25 [1] Group 1: Company Performance - The company is anticipated to benefit from improved economics in the aluminum market [1] Group 2: Analyst Background - Michael Del Monte, a buy-side equity analyst with over 5 years of experience, emphasizes that investment recommendations should consider the entire investment ecosystem rather than evaluating a company in isolation [1]

Core Insights - DexCom, Inc. is valued at a market cap of $25.5 billion and specializes in continuous glucose monitoring systems for diabetes management [1] - The company is expected to announce its fiscal Q3 earnings for 2025 on October 30, 2023 [1] Financial Performance - Analysts predict a profit of $0.57 per share for Q3 2025, representing a 26.7% increase from $0.45 per share in the same quarter last year [2] - For fiscal 2025, DexCom is expected to report a profit of $2.04 per share, up 24.4% from $1.64 per share in fiscal 2024, with further growth anticipated to $2.56 in fiscal 2026 [3] Stock Performance - DexCom shares have declined 4.7% over the past 52 weeks, underperforming the S&P 500 Index's 14.2% return, but have outperformed the Health Care Select Sector SPDR Fund's 7.5% decline [4] - Following better-than-expected Q2 results, DexCom's shares fell 9.3% in the subsequent trading session despite a 15.2% year-over-year revenue increase to $1.2 billion [5] Analyst Ratings - Wall Street analysts maintain a "Strong Buy" rating for DexCom, with 20 out of 27 analysts recommending "Strong Buy," one suggesting "Moderate Buy," and six indicating "Hold" [6] - The mean price target for DexCom is $100.24, suggesting a potential upside of 52.5% from current levels [6]

Core Viewpoint - Deckers Outdoor Corporation (DECK) is positioned for potential growth despite recent stock performance challenges, with upcoming earnings expected to reflect a slight profit decrease compared to the previous year [1][2]. Financial Performance - Analysts anticipate DECK will report a profit of $1.58 per share for fiscal Q2 2026, a slight decrease from $1.59 per share in the same quarter last year [2]. - For fiscal 2026, DECK is projected to achieve a profit of $6.35 per share, a marginal increase from $6.33 per share in fiscal 2025, with further growth expected to $6.82 per share in fiscal 2027, representing a year-over-year increase of 7.4% [3]. Recent Stock Performance - DECK's shares have declined by 40.2% over the past 52 weeks, significantly underperforming the S&P 500 Index, which rose by 13.4%, and the Consumer Discretionary Select Sector SPDR Fund, which increased by 17.4% during the same period [4]. - Following the release of better-than-expected Q1 results, DECK's shares surged by 11.4% in the subsequent trading session, with net sales rising by 16.9% year-over-year to $964.5 million, exceeding consensus estimates by 7.3% [5]. Analyst Sentiment - Wall Street analysts maintain a "Moderate Buy" rating for DECK, with 10 out of 25 analysts recommending "Strong Buy," one suggesting "Moderate Buy," 12 advising "Hold," and two indicating "Strong Sell" [6]. - The mean price target for DECK is set at $127.75, suggesting a potential upside of 34.4% from current levels [6].

Core Viewpoint - MetLife, Inc. is set to announce its fiscal third-quarter earnings for 2025, with analysts expecting a profit increase compared to the previous year [1][2]. Financial Performance - Analysts anticipate MetLife to report a profit of $2.30 per share on a diluted basis, reflecting a 19.2% increase from $1.93 per share in the same quarter last year [2]. - For the full fiscal year, the expected EPS is $8.66, which is a 6.8% increase from $8.11 in fiscal 2024, and projected to rise to $10.09 in fiscal 2026, marking a 16.5% year-over-year increase [3]. Stock Performance - MetLife's stock has underperformed the S&P 500 Index, which gained 13.4% over the past 52 weeks, with MetLife shares down 5.1% during the same period [4]. - The stock also lagged behind the Financial Select Sector SPDR Fund, which saw a 14.3% increase [4]. Recent Earnings Report - In its Q2 results, MetLife reported an adjusted EPS of $2.02, which missed Wall Street expectations of $2.19, and its revenue was $17.3 billion, down 2.7% year over year [5]. Analyst Ratings - The consensus opinion on MetLife stock is moderately bullish, with a "Moderate Buy" rating overall. Out of 19 analysts, 12 recommend a "Strong Buy," one a "Moderate Buy," and six a "Hold" [6]. - The average analyst price target for MetLife is $93.81, indicating a potential upside of 17.6% from current levels [6].

Core Insights - Cognizant Technology Solutions Corporation (CTSH) is a professional services company with a market cap of $32.1 billion, focusing on consulting, technology, and outsourcing services [1] - The company is expected to announce its fiscal third-quarter earnings for 2025 soon [1] Financial Performance - Analysts anticipate CTSH to report a profit of $1.29 per share for the upcoming quarter, reflecting a 3.2% increase from $1.25 per share in the same quarter last year [2] - For the full fiscal year, EPS is projected to be $5.15, an 8.4% increase from $4.75 in fiscal 2024, with further growth expected to $5.50 in fiscal 2026 [3] Stock Performance - CTSH stock has underperformed the S&P 500 Index, which gained 13.4% over the past 52 weeks, with CTSH shares down 11.7% during the same period [4] - The stock also lagged behind the Technology Select Sector SPDR Fund, which saw a 20.8% increase [4] Recent Earnings Report - On July 30, CTSH reported Q2 results, with adjusted EPS of $1.31, surpassing Wall Street's expectations of $1.26, and revenue of $5.3 billion, exceeding the forecast of $5.2 billion [5] - The company expects full-year adjusted EPS to be between $5.08 and $5.22, with revenue projected between $20.7 billion and $21.1 billion [5] Analyst Ratings - The consensus opinion on CTSH stock is moderately bullish, with a "Moderate Buy" rating overall; out of 23 analysts, six recommend a "Strong Buy," one a "Moderate Buy," and 16 a "Hold" [6] - The average analyst price target for CTSH is $87.47, indicating a potential upside of 32.9% from current levels [6]

Group 1 - The article does not provide any specific content related to a company or industry [1]

Core Insights - Martin Marietta Materials, Inc. is a natural resource-based building materials company with a market cap of $38.4 billion, supplying aggregates and building materials to the construction industry [1] Financial Performance - The company is expected to report a profit of $6.62 per share for Q3, reflecting a 12% increase from $5.91 per share in the same quarter last year [2] - For the full fiscal year 2025, EPS is projected to be $18.92, a decrease of 41.6% from $32.41 in 2024, but is expected to grow by 14% year-over-year to $21.56 in fiscal 2026 [3] Stock Performance - MLM stock has increased by 19.3% over the past 52 weeks, outperforming the Materials Select Sector SPDR Fund's decline of 6.7% and the S&P 500 Index's return of 16.3% during the same period [4] Recent Results - Following the release of mixed Q2 results, the stock saw a slight gain. Q2 revenues reached $1.8 billion, a 2.7% year-over-year increase, although it fell short of Street expectations by 33 basis points [5] - The company's EPS for Q2 rose by 14.1% year-over-year to $5.43, surpassing consensus estimates by 2.1% [6] Analyst Sentiment - Analysts maintain a consensus "Moderate Buy" rating for MLM, with 12 out of 20 analysts recommending "Strong Buys," one suggesting "Moderate Buy," and seven advising "Holds." The stock is currently trading slightly below its mean price target of $645.69 [7]